Establishment of Hepatocellular Cancer Induced Pluripotent Stem Cells Using a Reprogramming Technique
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Cancer is known to be a disease by many factors. However, specific results of reprogramming by pluripotency-related transcription factors remain to be scarcely reported. Here, we verified potential effects of pluripotent-related genes in hepatocellular carcinoma cancer cells. Methods: To better understand reprogramming of cancer cells in different genetic backgrounds, we used four liver cancer cell lines representing different states of p53 (HepG2, Hep3B, Huh7 and PLC). Retroviral-mediated introduction of reprogramming related genes (KLF4, Oct4, Sox2, and Myc) was used to induce the expression of proteins related to a pluripotent status in liver cancer cells. Results: Hep3B cells (null p53) exhibited a higher efficiency of reprogramming in comparison to the other liver cancer cell lines. The reprogrammed Hep3B cells acquired similar characteristics to pluripotent stem cells. However, loss of stemness in Hep3B-iPCs was detected during continual passage. Conclusions: We demonstrated that reprogramming was achieved in tumor cells through retroviral induction of genes associated with reprogramming. Interestingly, the reprogrammed pluripotent cancer cells (iPCs) were very different from original cancer cells in terms of colony shape and expressed markers. The induction of pluripotency of liver cancer cells correlated with the status of p53, suggesting that different expression level of p53 in cancer cells may affect their reprogramming.
Abstract
Background/Aims: Cancer is known to be a disease by many factors. However, specific results of reprogramming by pluripotency-related transcription factors remain to be scarcely reported. Here, we verified potential effects of pluripotent-related genes in hepatocellular carcinoma cancer cells. Methods: To better understand reprogramming of cancer cells in different genetic backgrounds, we used four liver cancer cell lines representing different states of p53 (HepG2, Hep3B, Huh7 and PLC). Retroviral-mediated introduction of reprogramming related genes (KLF4, Oct4, Sox2, and Myc) was used to induce the expression of proteins related to a pluripotent status in liver cancer cells. Results: Hep3B cells (null p53) exhibited a higher efficiency of reprogramming in comparison to the other liver cancer cell lines. The reprogrammed Hep3B cells acquired similar characteristics to pluripotent stem cells. However, loss of stemness in Hep3B-iPCs was detected during continual passage. Conclusions: We demonstrated that reprogramming was achieved in tumor cells through retroviral induction of genes associated with reprogramming. Interestingly, the reprogrammed pluripotent cancer cells (iPCs) were very different from original cancer cells in terms of colony shape and expressed markers. The induction of pluripotency of liver cancer cells correlated with the status of p53, suggesting that different expression level of p53 in cancer cells may affect their reprogramming.
참고문헌 (26)
- Reya T, "Stem cells, cancer, and cancer stem cells", Nature, 414, pp.105~111 (2001)
- Pardal R, "Applying the principles of stemcell biology to cancer", Nat Rev Cancer, 3, pp.895~902 (2003)
- Du L, "CD44 is of functional importance for colorectal cancer stem cells", Clin Cancer Res, 14, pp.6751~6760 (2008)
- Singh SK, "Identification of human brain tumour initiating cells", Nature, 432, pp.396~401 (2004)
- Kim CF, "Identification of bronchioalveolar stem cells in normal lung and lung cancer", Cell, 121, pp.823~835 (2005)
- O’Brien CA, "A human colon cancer cell capable of initiating tumour growth in immunodeficient mice", Nature, 445, pp.106~110 (2007)
- Ma S, "Identification and characterization of tumorigenic liver cancer stem", progenitor cells, 2007, pp.132, 2542~2556
- McGlynn KA, "The global epidemiology of hepatocellular carcinoma: present and future", Clin Liver Dis, 15, pp.223~243 (2011)
- Song IH, "Current status of liver diseases in Korea: hepatocellular carcinoma", Korean J Hepatol, 15(Suppl 6), pp.S50~S59 (2009)
- Haraguchi N, "Characterization of a side population of cancer cells from human gastrointestinal system", Stem Cells, 24, pp.506~513 (2006)
- Ding W, "CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosis", Hepatology, 49, pp.1277~1286 (2009)
- Zhu Z, "Cancer stem", progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma, 2010, pp.126, 2067~2078
- Yang ZF, "Significance of CD90+ cancer stem cells in human liver cancer", Cancer Cell, 13, pp.153~166 (2008)
- Yamashita T, "EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem", progenitor cell features, 2009, pp.136, 1012~1024
- Thomson JA, "Embryonic stem cell lines derived from human blastocysts", Science, 282, pp.1145~1147 (1998)
- Hochedlinger K, "Nuclear reprogramming and pluripotency", Nature, 441, pp.1061~1067 (2006)
- Loh YH, "The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells", Nat Genet, 38, pp.431~440 (2006)
- Wu Q, "Sall4 interacts with Nanog and co-occupies Nanog genomic sites in embryonic stem cells", J Biol Chem, 281, pp.24090~24094 (2006)
- Zheng YW, "Cellular reprogramming and hepatocellular carcinoma development", World J Gastroenterol, 19, pp.8850~8860 (2013)
- Sun C, "Induced pluripotent cancer cells: progress and application", J Cancer Res Clin Oncol, 137, pp.1~8 (2011)
- Hong H, "Suppression of induced pluripotent stem cell generation by the p53-p21 pathway", Nature, 460, pp.1132~1135 (2009)
- Tanabe K, "Maturation, not initiation, is the major roadblock during reprogramming toward pluripotency from human fibroblasts", Proc Natl Acad Sci U S A, 110, pp.12172~12179 (2013)
- Martí M, "Characterization of pluripotent stem cells", Nat Protoc, 8, pp.223~253 (2013)
- Welte Y, "Cancer stem cells in solid tumors: elusive or illusive", Cell Commun Signal, 8, pp.6~ (2010)
- Yu J, "Human induced pluripotent stem cells free of vector and transgene sequences", Science, 324, pp.797~801 (2009)
- Kwon YJ, "Clinical implications of advances in liver regeneration", Clin Mol Hepatol, 21, pp.7~13 (2015)